Economic evaluation of rivaroxaban versus enoxaparin for prevention of venous thromboembolism after total knee replacement and total hip replacement: a …

A Rashki Kemmak, A Abutorabi, V Alipour - Clinical Drug Investigation, 2020 - Springer
Background Deep vein thrombosis (DVT) and pulmonary embolism (PE) together are called
venous thromboembolism (VTE) and impose a high economic burden on healthcare …

Venous thromboembolism after shoulder arthoplasty and arthroscopy

CM Rapp, EJ Shields, BP Wiater… - JAAOS-Journal of the …, 2019 - journals.lww.com
Venous thromboembolism (VTE) in the orthopaedic literature largely focuses on lower
extremity trauma and arthroplasty, with relatively few investigations of VTE after shoulder …

[HTML][HTML] New anticoagulants for the prevention and treatment of venous thromboembolism

JH Kim, KM Lim, HS Gwak - Biomolecules & therapeutics, 2017 - ncbi.nlm.nih.gov
Anticoagulant drugs, like vitamin K antagonists and heparin, have been the mainstay for the
treatment and prevention of venous thromboembolic disease for many years. Although …

Incidence of hospital readmission in patients diagnosed with DVT and PE: clinical burden of recurrent events

EA Nutescu, C Crivera, JR Schein… - International Journal of …, 2015 - Wiley Online Library
Background Venous thromboembolism (VTE), which comprises deep‐vein thrombosis
(DVT) and pulmonary embolism (PE), is associated with significant morbidity and mortality …

Cost-effectiveness of apixaban versus other oral anticoagulants for the initial treatment of venous thromboembolism and prevention of recurrence

T Lanitis, R Leipold, M Hamilton, D Rublee, P Quon… - Clinical …, 2016 - Elsevier
Purpose To assess the cost-effectiveness of apixaban versus rivaroxaban, low-molecular-
weight heparin (LMWH)/dabigatran, and LMWH/vitamin K antagonist (VKA) for the initial …

Characterizing the relationship between age and venous thromboembolism in adult trauma patients: findings from the National Trauma Data Bank and the National …

AJ Nastasi, JK Canner, BD Lau, MB Streiff… - journal of surgical …, 2017 - Elsevier
Background Venous thromboembolism (VTE) is a tremendous burden in health care.
However, current guidelines lack recommendations regarding the prevention of VTE in older …

Incidence of deep vein thrombosis and pulmonary embolus following periacetabular osteotomy

I Zaltz, P Beaulé, J Clohisy, P Schoenecker, D Sucato… - JBJS, 2011 - journals.lww.com
Background: Venous thromboembolism, a known complication of orthopaedic procedures, is
thought to be more prevalent following hip surgery. Venous thromboembolism risk …

Apixaban: a new player in the anticoagulant class

R Agrawal, P Jain, SN Dikshit - Current Drug Targets, 2012 - ingentaconnect.com
Apixaban (BMS-562247-01) is a compound being investigated as an anticoagulant.
Apixaban molecule is developed in a joint venture by Pfizer and Bristol-Myers Squibb …

Rapid extraction and purification of lumbrokinase from Lumbricus rubellus using a hollow fiber membrane and size exclusion chromatography

T Fu, F Yang, H Zhu, H Zhu, L Guo - Biotechnology letters, 2016 - Springer
Objectives To develop a purification process using hollow fiber membrane separation
combined with size exclusion chromatography for the extraction of lumbrokinase from …

单侧全膝关节置换术后依诺肝素与利伐沙班抗凝效果的随机对照研究

王炜, 翁习生, 林进, 金今, 钱文伟, 邱贵兴 - 中国骨与关节外科, 2012 - cqvip.com
背景: 全膝关节置换(total knee arthroplasty, TKA) 术后使用低分子肝素抗凝已被证实具有较好
的有效性和安全性, 而新的口服抗凝药物—利伐沙班在中国患者中的临床效果有待证实. 目的 …